Control mechanisms of human basophil releasability.

[1]  M. Condorelli,et al.  Human basophil releasability. I. Age-related changes in basophil releasability. , 1986, The Journal of allergy and clinical immunology.

[2]  M. Condorelli,et al.  The mechanism of basophil histamine release induced by pepstatin A. , 1984, Journal of immunology.

[3]  M. Condorelli,et al.  Inhibition of histamine release from human basophils in vitro by calmodulin antagonists. , 1983, Clinical immunology and immunopathology.

[4]  G. Prinzi,et al.  Familial incidence of twinning , 1983, Nature.

[5]  M. Condorelli,et al.  Possible role of calmodulin in human inflammatory reactions. , 1983, Monographs in allergy.

[6]  M. Condorelli,et al.  Histamine release from human basophils in vitro: effects of age of cell donor. , 1983, Monographs in allergy.

[7]  G. Marone,et al.  Progress in clinical immunology. The role of chemical mediators and cellular interactions. 14th Symposium of the Collegium Internationale Allergologicum, Sorrento, October 10-14, 1982. , 1983, Monographs in allergy.

[8]  S. Holgate,et al.  Characterization of histamine secretion from mechanically dispersed human lung mast cells: effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides. , 1982, Journal of immunology.

[9]  L. Lichtenstein,et al.  In vitro histamine release from basophils of asthmatic and atopic individuals in D2O. , 1982, Journal of immunology.

[10]  T. Ishizaka.  Biochemical analysis of triggering signals induced by bridging of IgE receptors. , 1982, Federation proceedings.

[11]  M. Kaliner,et al.  The mast cell. , 1981, Critical reviews in immunology.

[12]  M. A. Bray,et al.  Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes , 1980, Nature.

[13]  L. Lichtenstein,et al.  Basophil "releasability" in patients with asthma. , 1980, The American review of respiratory disease.

[14]  D. Hanahan,et al.  Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). , 1979, The Journal of biological chemistry.

[15]  L. Lichtenstein,et al.  Adenosine receptor on human basophils: modulation of histamine release. , 1979, Journal of immunology.

[16]  R. Murphy,et al.  Leukotriene C: a slow-reacting substance from murine mastocytoma cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[17]  B. W. Erickson,et al.  Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release. , 1979, The Journal of clinical investigation.

[18]  L. Lichtenstein,et al.  Differences between histamine release from rat mast cells and human basophils and mast cells , 1979 .

[19]  L. Lichtenstein,et al.  IgE receptors on human basophils. Relationship to serum IgE concentration. , 1978, The Journal of clinical investigation.

[20]  L. Lichtenstein,et al.  The clinical and immunologic specificity of immunotherapy. , 1978, The Journal of allergy and clinical immunology.

[21]  L. Lichtenstein,et al.  RELATIONSHIP TO SERUM IgE CONCENTRATION , 1978 .

[22]  J. Fleisch,et al.  Reduction in antigen-induced release of histamine and slow reacting substance of anaphylaxis from guinea pig lung with increasing age. , 1978, Biochemical pharmacology.

[23]  L. Lichtenstein,et al.  Measurement of IgE on human basophils: relation to serum IgE and anti-IgE-induced histamine release. , 1977, Journal of immunology.

[24]  L. Lichtenstein,et al.  Defective release of eosinophil chemotactic factor from peripheral leukocytes in patients with chronic urticaria. , 1976, The Journal of investigative dermatology.

[25]  L. Lichtenstein,et al.  Defective histamine release in chronic urticaria. , 1976, The Journal of clinical investigation.

[26]  D. Crowther.  Progress in Clinical Immunology , 1975 .

[27]  M. Bazaral,et al.  Genetics of IgE and allergy: Serum IgE levels in twins , 1974 .

[28]  C. May,et al.  Immunochemical effects of injection therapy with allergens by customary and intensive dosage regimens in children. , 1972, Pediatrics.

[29]  L. Lichtenstein,et al.  Immunologic and cellular changes accompanying the therapy of pollen allergy. , 1971, The Journal of clinical investigation.

[30]  T. Aoyagi,et al.  Pepstatin, a new pepsin inhibitor produced by Actinomycetes. , 1970, The Journal of antibiotics.

[31]  L. Lichtenstein,et al.  Clinical and in vitro studies on the role of immunotherapy in ragweed hay fever. , 1968, The American journal of medicine.

[32]  K. Austen,et al.  Immunological Histamine Release from Rat Mast Cells in vitro , 1965 .

[33]  H. H. Strandskov.  Heredity in bronchial asthma , 1953 .

[34]  F. M. Rackemann.  THE ASTHMA PROBLEM , 1952, Acta allergologica.

[35]  J. Adkinson.  The Behavior of Bronchial Asthma as an Inherited Character. , 1920, Genetics.